Evidence map›Paper›PMID 25478862›Full record

ArticlePloS one2014

Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors.

Marilys Corbex, Sabiha Bouzbid, Alexandra Traverse-Glehen, Hayette Aouras, Sandrine McKay-Chopin, Christine Carreira, Abdelaziz Lankar, Massimo Tommasino, Tarik Gheit

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. HPV-Associated Breast Cancer: Myth or Fact?Pathogens (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Review
  17. Clinical implications of alpha, beta, and gamma HPV infection in juvenile onset recurrent respiratory papillomatosis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Marilys CorbexUniversité Libre de Bruxelles, Brussels, Belgium.
Sabiha BouzbidBadji Mokhtar University, Faculty of Medicine, Annaba, Algeria; University Hospital, Annaba, Algeria.
Alexandra Traverse-GlehenHospices Civils de Lyon, Laboratoire d'Anatomie Pathologique, Université Lyon 1, Lyon, France.
Hayette AourasBadji Mokhtar University, Faculty of Medicine, Annaba, Algeria; University Hospital, Annaba, Algeria.
Sandrine McKay-ChopinInfections and Cancer Biology Group, International Agency for Research on Cancer, Lyon, France.
Christine CarreiraMolecular Pathology Group, International Agency for Research on Cancer, Lyon, France.
Abdelaziz LankarBadji Mokhtar University, Faculty of Medicine, Annaba, Algeria; University Hospital, Annaba, Algeria; Cytology and pathology laboratory, University Hospital, Annaba, Algeria.
Massimo TommasinoInfections and Cancer Biology Group, International Agency for Research on Cancer, Lyon, France.
Tarik GheitInfections and Cancer Biology Group, International Agency for Research on Cancer, Lyon, France.
Centre International de Recherche sur le Cancer · FRBadji Mokhtar University · DZUniversité Claude Bernard Lyon 1 · FRUniversité Libre de Bruxelles · BE

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe possible role of viruses in breast cancer etiology remains an unresolved question. We hypothesized that if some viruses are involved, it may be in a subgroup of breast cancers only. Epidemiological arguments drove our interest in breast cancer subgroups that are more frequent in Africa, namely inflammatory breast cancer (IBC) and triple-negative breast cancer. We tested whether viral prevalence was significantly higher in these subgroups. MATERIALS AND

methodsOne hundred fifty-five paraffin-embedded malignant breast tumors were randomly selected at the pathology laboratory of the University Hospital of Annaba (Algeria) to include one third of IBC and two thirds of non-IBC. They were tested for the presence of DNA from 61 viral agents (46 human papillomaviruses, 10 polyomaviruses, and 5 herpesviruses) using type-specific multiplex genotyping assays, which combine multiplex PCR and bead-based Luminex technology.

resultsViral DNA was found in 22 (17.9%) of 123 tumors. The most prevalent viruses were EBV1 and HPV16. IBC tumors carried significantly more viruses (any type) than non-IBC tumors (30% vs. 13%, p<0.04). Similarly, triple-negative tumors displayed higher virus-positivity than non-triple-negative tumors (44% vs. 14%, p<0.009).

conclusionsOur results suggest an association between the presence of viral DNA and aggressive breast cancer phenotypes (IBC, triple-negative). While preliminary, they underline the importance of focusing on subgroups when studying viral etiology in breast cancer. Further studies on viruses in breast cancer should be conducted in much larger samples to confirm these initial findings.

Indexed as

Breast NeoplasmsHerpesviridaeHuman papillomavirus 16PolyomavirusAdultAlgeriaFemaleHerpesviridae InfectionsHumansMiddle AgedPapillomavirus InfectionsPolyomavirus InfectionsTumor Virus Infections

Identifiers

PMID25478862
PMCPMC4257687
OpenAlexW2093101811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.